A good growth outlook is seen for GSK Plc ADR (GSK) Stock by analysts
Goldman raised the price target for the GSK Plc ADR (NYSE:GSK) stock to “a Neutral”. The rating was released on May 30, 2024, according to finviz. The stock was initiated by Morgan Stanley, who disclosed in a research note on January 23, 2024, to Equal-Weight and set the price objective to $44. The latest trade, […]
